{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:55:18Z","timestamp":1793678118374,"version":"4.5.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1038\/s41433-022-02280-3","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T14:04:14Z","timestamp":1666274654000},"page":"988-994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Post-enucleation outcomes of patients with uveal melanoma in Scotland"],"prefix":"10.1038","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7747-1041","authenticated-orcid":false,"given":"Deep","family":"Sarode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"McClay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7881-0922","authenticated-orcid":false,"given":"Paul","family":"Cauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0330-7548","authenticated-orcid":false,"given":"Vikas","family":"Chadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"2280_CR1","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","volume":"114","author":"G Virgili","year":"2007","unstructured":"Virgili G, Gatta G, Ciccolallo L, Capocaccia R, BiggeriZ A, Crocetti E, et al. Incidence of uveal melanoma in Europe. Ophthalmology 2007;114:2309\u201315.","journal-title":"Ophthalmology"},{"key":"2280_CR2","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/cncr.20866","volume":"103","author":"CC McLaughlin","year":"2005","unstructured":"McLaughlin CC, Wu X-C, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the U.S. Cancer [Internet] 2005;103:1000\u20137. https:\/\/doi.org\/10.1002\/cncr.20866.","journal-title":"Cancer [Internet]"},{"key":"2280_CR3","doi-asserted-by":"publisher","unstructured":"Beasley AB, Preen DB, McLenachan S, Gray ES, Chen FK. Incidence and mortality of uveal melanoma in Australia (1982\u20132014). Br J Ophthalmol. 2021. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-319700.","DOI":"10.1136\/bjophthalmol-2021-319700"},{"key":"2280_CR4","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1038\/s41433-019-0622-9","volume":"33","author":"A Jamison","year":"2019","unstructured":"Jamison A, Bhatti LA, Sobti MM, Chadha V, Cauchi P, Kemp EG. Uveal melanoma-associated survival in Scotland. Eye (Lond). 2019;33:1699\u2013706.","journal-title":"Eye (Lond)"},{"key":"2280_CR5","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","volume":"124","author":"Collaborative Ocular Melanoma Study Group.","year":"2006","unstructured":"Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol 2006;124:1684\u201393.","journal-title":"Arch Ophthalmol"},{"key":"2280_CR6","doi-asserted-by":"publisher","unstructured":"Shields C, Dockery P, Mayro E, Bas Z, Yaghy A, Lally S, et al. Conditional survival of uveal melanoma using The Cancer Genome Atlas (TCGA) classification (Simplified Version) in 1001 cases. Saudi J Ophthalmol. 2022. https:\/\/doi.org\/10.4103\/SJOPT.SJOPT_69_21.","DOI":"10.4103\/SJOPT.SJOPT_69_21"},{"key":"2280_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/eye.2016.275","volume":"31","author":"S Kaliki","year":"2017","unstructured":"Kaliki S, Shields CL. Uveal melanoma: relatively rare but deadly cancer. Eye [Internet] 2017;31:241\u201357. http:\/\/www.nature.com\/articles\/eye2016275.","journal-title":"Eye [Internet]"},{"key":"2280_CR8","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archopht.119.7.969","volume":"119","author":"M Diener-West","year":"2001","unstructured":"Diener-West M, Earle J, Fine S, Hawkins B, Moy C, Reynolds S, et al. Collaborative Ocular Melanoma Study Group: The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III. Arch Ophthalmol. 2001;119:969\u201382.","journal-title":"Arch Ophthalmol"},{"key":"2280_CR9","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1001\/archopht.118.8.1066","volume":"118","author":"W Li","year":"2000","unstructured":"Li W, Gragoudas ES, Egan KM. Metastatic melanoma death rates by anatomic site after proton beam irradiation for uveal melanoma. Arch Ophthalmol (Chic, Ill 1960) [Internet] 2000;118:1066\u201370. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10922199.","journal-title":"Arch Ophthalmol (Chic, Ill 1960) [Internet]"},{"key":"2280_CR10","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1167\/iovs.13-13670","volume":"55","author":"JGM van Beek","year":"2014","unstructured":"van Beek JGM, Koopmans AE, Vaarwater J, de Rooi JJ, Paridaens D, Naus NC, et al. The Prognostic Value of Extraocular Extension in Relation to Monosomy 3 and Gain of Chromosome 8q in Uveal Melanoma. Investig Opthalmology Vis Sci [Internet] 2014;55:1284 http:\/\/iovs.arvojournals.org\/article.aspx?","journal-title":"Investig Opthalmology Vis Sci [Internet]"},{"key":"2280_CR11","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","volume":"44","author":"E Kujala","year":"2003","unstructured":"Kujala E, Makitie T, Kivela T. Very Long-Term Prognosis of Patients with Malignant Uveal Melanoma. Investig Opthalmology Vis Sci [Internet] 2003;44:4651 http:\/\/iovs.arvojournals.org\/article.aspx?","journal-title":"Investig Opthalmology Vis Sci [Internet]"},{"key":"2280_CR12","first-page":"239","volume":"11","author":"A Singh","year":"2014","unstructured":"Singh A, Shields C, Shields J. Prognostic factors in uveal melanoma. Clin Ophthalmic Oncol Uveal Tumors. 2014;11:239\u201348.","journal-title":"Clin Ophthalmic Oncol Uveal Tumors"},{"key":"2280_CR13","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.ophtha.2008.04.025","volume":"115","author":"SE Coupland","year":"2008","unstructured":"Coupland SE, Campbell I, Damato B. Routes of Extraocular Extension of Uveal Melanoma. Risk Factors and Influence on Survival Probability. Ophthalmology 2008;115:1778\u201385.","journal-title":"Ophthalmology"},{"key":"2280_CR14","doi-asserted-by":"crossref","unstructured":"Hykin PG, Mccartney ACE, Plowman PN, Hungerford JL. Postenucleation orbital radiotherapy for the treatment of malignant melanoma of the choroid with extrascleral extension [Internet]. 74, Br J Ophthalmol. 1990 [cited 2020 Oct 9]. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1041975\/pdf\/brjopthal00575-0044.pdf.","DOI":"10.1136\/bjo.74.1.36"},{"key":"2280_CR15","unstructured":"Roelofs KA, Cohen VML, Sagoo MS, Plowman PN, Negretti GS, O\u2019Day R, et al. Adjuvant External Beam Radiotherapy Following Enucleation of Eyes With Extraocular Extension From Uveal Melanoma. Ophthalmic Plast Reconstr Surg [Internet]. 2020 [cited 2020 Oct 16];Publish Ah. https:\/\/journals.lww.com\/10.1097\/IOP.0000000000001800"},{"key":"2280_CR16","unstructured":"Mudhar HS, Coupland SE. Dataset for histopathological reporting of uveal melanoma. 5th ed [Internet]. 2021. Available from: https:\/\/www.rcpath.org\/uploads\/assets\/7baa5a48-e3fc-4dc8-b0e36c5a5c9a194b\/778f7dc3-135a-4590-aaeec103048a492f\/G056-Dataset-for-histopathological-reporting-of-uveal-melanoma.pdf."},{"key":"2280_CR17","unstructured":"Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. editors. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2016. p. 805\u201317."},{"key":"2280_CR18","unstructured":"Cursiefen C, Kruse FE, Naumann GOH. Cornea and limbus. Appl Pathol Ophthalmic Microsurg. Berlin: Springer; 2008. p. 97\u2013130."},{"key":"2280_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ophtha.2009.06.057","volume":"117","author":"LM Heindl","year":"2010","unstructured":"Heindl LM, Hofmann TN, Adler W, Knorr HLJ, Holbach LM, Naumann GOH, et al. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension? Ophthalmology 2010;117:334\u201342. https:\/\/doi.org\/10.1016\/j.ophtha.2009.06.057.","journal-title":"Ophthalmology"},{"key":"2280_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/01676830.2017.1423083","volume":"37","author":"CKH Burris","year":"2018","unstructured":"Burris CKH, Papastefanou VP, Thaung C, Restori M, Arora AK, Sagoo M, et al. Detection of Extrascleral Extension in Uveal melanoma with Histopathological Correlation. Orbit 2018;37:287\u201392. https:\/\/doi.org\/10.1080\/01676830.2017.1423083.","journal-title":"Orbit"},{"key":"2280_CR21","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1038\/s41433-021-01710-y","volume":"36","author":"GS Negretti","year":"2022","unstructured":"Negretti GS, Gurudas S, Gallo B, Damato B, Arora AK, Sivaprasad S, et al. Survival analysis following enucleation for uveal melanoma. Eye. 2022;36:1669\u201374.","journal-title":"Eye"},{"key":"2280_CR22","doi-asserted-by":"crossref","unstructured":"Bergeron E, Lihimdi N, Bergeron D, Landreville S. Orbital recurrence of iris melanoma 21 years after enucleation. BMJ Case Rep [Internet]. 2017 [cited 2021 Dec 14];2017. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28882848.","DOI":"10.1136\/bcr-2017-221137"},{"key":"2280_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0039-6257(02)00458-7","volume":"48","author":"N Mittica","year":"2003","unstructured":"Mittica N, Vemuganti GK, Duffy M, Torczynski E, Edward DP. Late orbital recurrence of a choroidal melanoma following internal resection: Report of a case and review of the literature. Surv Ophthalmol. 2003;48:181\u201390.","journal-title":"Surv Ophthalmol"},{"key":"2280_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ophtha.2015.09.014","volume":"123","author":"BL Gallie","year":"2016","unstructured":"Gallie BL, Simpson ER, Saakyan S, Amiryan A, Valskiy V, Finger PT, et al. Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma. Ophthalmology 2016;123:86\u201391.","journal-title":"Ophthalmology"},{"key":"2280_CR25","first-page":"2197","volume":"109","author":"LM Jampol","year":"2002","unstructured":"Jampol LM, Moy CS, Murray TG, Reynolds SM, Albert DM, Schachat AP, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS Rep. no 19 Ophthalmol 2002;109:2197\u2013206.","journal-title":"COMS Rep. no 19 Ophthalmol"},{"key":"2280_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-022-02387-x","volume":"22","author":"H Wang","year":"2022","unstructured":"Wang H, Zhang R, Wang Y, Chen R, Liu Y, Li Y, et al. Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy. BMC Ophthalmol. 2022;22:163.","journal-title":"BMC Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02280-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02280-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02280-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T12:17:24Z","timestamp":1680005844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02280-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2280"],"URL":"https:\/\/doi.org\/10.1038\/s41433-022-02280-3","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"assertion":[{"value":"1 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}